# The Effect of Intradialytic Parenteral Nutrition on Nutritional Status and Quality of Life in Hemodialysis Patients

Study · id `cardio:ct-nct04094038` · Cardiovascular Atlas · release `a25293eeae6350fb` (public)

> General information from published sources, not medical advice, and not reviewed by clinicians. Check the cited source before relying on anything here. Sponsors do not influence what this atlas says.

The atlas's own text and curation may be reused under Creative Commons Attribution-NonCommercial 4.0 International (CC BY-NC 4.0, https://creativecommons.org/licenses/by-nc/4.0/): credit the atlas, and do not use it commercially without a licence from the owner. See the atlas About page. Text quoted from a source stays under that source's own terms, given as the source's reuse\_basis. The atlas's reuse terms do not cover it. The downloads list each quotation with its source in third\_party\_quotations.

**Registry record.** Assembled by a program from [ClinicalTrials.gov record NCT04094038](<https://clinicaltrials.gov/study/NCT04094038>), retrieved 26 October 2026. No person wrote or checked this page.

Also called: NCT04094038

Browse, organ or system: Kidneys  
Browse, condition area: Kidney connections  

## In plain language

A phase 4 trial registered on ClinicalTrials.gov. The registry status is active, not recruiting. It plans to enroll 166 participants.

## Technical summary

Registry record NCT04094038. Randomized; quadruple masking; primary purpose treatment. Start 2019-09-16 (actual); primary completion 2024-04-02 (actual). Results not posted.

## Key facts

- Design: Interventional study; randomized; quadruple masking; primary purpose treatment
- Phase: Phase 4
- Enrolled: 166 participants (planned count; ClinicalTrials.gov record NCT04094038, source copy `cardio:ctgov-nct04094038-2026-02-12`, retrieved 2026-10-26)
- Started: 2019-09-16 (actual) (ClinicalTrials.gov record NCT04094038, source copy `cardio:ctgov-nct04094038-2026-02-12`, retrieved 2026-10-26)
- Primary completion: 2024-04-02 (actual) (ClinicalTrials.gov record NCT04094038, source copy `cardio:ctgov-nct04094038-2026-02-12`, retrieved 2026-10-26)
- Completion: 2026-07 (anticipated) (ClinicalTrials.gov record NCT04094038, source copy `cardio:ctgov-nct04094038-2026-02-12`, retrieved 2026-10-26)
- Countries: Netherlands (ClinicalTrials.gov record NCT04094038, source copy `cardio:ctgov-nct04094038-2026-02-12`, retrieved 2026-10-26)
- Care setting: Not reported
- Registry status: "ACTIVE\_NOT\_RECRUITING" (U.S. National Library of Medicine (ClinicalTrials.gov), source copy `cardio:ctgov-nct04094038-2026-02-12`, retrieved 2026-10-26)

## The registry's words

- Brief title: The Effect of Intradialytic Parenteral Nutrition on Nutritional Status and Quality of Life in Hemodialysis Patients
- Condition: End Stage Renal Disease
- Condition: Malnutrition
- Condition: Sarcopenia
- Condition: Hemodialysis Complication
- Intervention (Drug): Olimel N12
- Intervention (Drug): Glucose IV
- Lead sponsor: Erasmus Medical Center
- Lead sponsor class: OTHER
- Collaborator: Baxter Healthcare Corporation
- Collaborator class: INDUSTRY

## Connected pages

- Registry condition terms include this condition: Chronic kidney disease (CKD) (`cardio:chronic-kidney-disease`)
- Registry lists this organization as the lead sponsor: Erasmus Medical Center (`cardio:org-erasmus-medical-center`)
- Registry lists this organization as a collaborator: Baxter Healthcare Corporation (`cardio:org-baxter-healthcare-corporation`)

## Provenance

Content hash: 7c26be499feb32558b96ac1e1cef9dc0663dc9b0b995a451b7610da639ef3b26
Last substantive edit: 2026-11-08
Evidence last checked: Not recorded
